Insulet (PODD +10.6%) gets lifted today after its Q1 easily beat estimates. Revenue and gross...


Insulet (PODD +10.6%) gets lifted today after its Q1 easily beat estimates. Revenue and gross profit increased by over 20% Y/Y, boosted by strong demand for its new OmniPod Insulin Pump. For the full year 2013, the company reiterates its revenue view of $240M to $255M, above the Street view of $248.4M.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs